Local distribution infrastructure and robust vaccine manufacturing facilities in LMICs should be prioritised to tackle ongoing and future pandemic risk-Reference-Cited by-同舟云学术

Local distribution infrastructure and robust vaccine manufacturing facilities in LMICs should be prioritised to tackle ongoing and future pandemic risk

Published:2023-04 Issue: Volume:11 Page:100158
ISSN:2772-3682
Container-title:The Lancet Regional Health - Southeast Asia
language:en
Short-container-title:The Lancet Regional Health - Southeast Asia

Author:

Reza Hasan Mahmud^ORCID,Sultana Farhana,Bari Razmin,Cole Jennifer^ORCID,Baqui Abdullah H.

Publisher

Elsevier BV

Reference14 articles.

1. The Lancet Commission on lessons for the future from the COVID-19 pandemic;Sachs;Lancet,2022

2. COVID-19 vaccine acceptance and hesitancy in low-and middle-income countries;Solís Arce;Nat Med,2021

3. Why are vaccination rates lower in low and middle income countries, and what can we do about it?;Reza;BMJ,2022

4. Unhealthy geopolitics? Bordering disease in the time of coronavirus;Cole;Geogr Res,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 Vaccination and Public Health: Addressing Global, Regional, and Within-Country Inequalities;Vaccines;2024-08-04

2. Examining the interplay between HPV knowledge and participants’ propensity for vaccination;Pharmacia;2024-08-02

3. Policy perspectives on the sustainable introduction of pneumococcal conjugate vaccines in middle-income countries;2024-06-10

4. Dry and liquid formulations of IBT-V02, a novel multi-component toxoid vaccine, are effective against Staphylococcus aureus isolates from low-to-middle income countries;Frontiers in Immunology;2024-04-03

5. Unlocking cancer vaccine potential: What are the key factors?;Human Vaccines & Immunotherapeutics;2024-04-02